BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37864794)

  • 1. Lung cDC1 and cDC2 dendritic cells priming naive CD8
    Si Y; Wang Y; Tian Q; Wang Q; Pollard JM; Srivastava PK; Esser-Kahn AP; Collier JH; Sperling AI; Chong AS
    Cell Rep; 2023 Oct; 42(10):113299. PubMed ID: 37864794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDC1 prime and are licensed by CD4
    Ferris ST; Durai V; Wu R; Theisen DJ; Ward JP; Bern MD; Davidson JT; Bagadia P; Liu T; Briseño CG; Li L; Gillanders WE; Wu GF; Yokoyama WM; Murphy TL; Schreiber RD; Murphy KM
    Nature; 2020 Aug; 584(7822):624-629. PubMed ID: 32788723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
    Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
    Sakurai S; Furuhashi K; Horiguchi R; Nihashi F; Yasui H; Karayama M; Suzuki Y; Hozumi H; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    Allergol Int; 2021 Jul; 70(3):351-359. PubMed ID: 33674189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.
    Cerovic V; Houston SA; Westlund J; Utriainen L; Davison ES; Scott CL; Bain CC; Joeris T; Agace WW; Kroczek RA; Mowat AM; Yrlid U; Milling SW
    Mucosal Immunol; 2015 Jan; 8(1):38-48. PubMed ID: 24850430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors.
    López L; Morosi LG; La Terza F; Bourdely P; Rospo G; Amadio R; Piperno GM; Russo V; Volponi C; Vodret S; Joshi S; Giannese F; Lazarevic D; Germano G; Stoitzner P; Bardelli A; Dalod M; Pace L; Caronni N; Guermonprez P; Benvenuti F
    Nat Commun; 2024 Mar; 15(1):2280. PubMed ID: 38480738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen.
    Takamura S; Roberts AD; Jelley-Gibbs DM; Wittmer ST; Kohlmeier JE; Woodland DL
    J Exp Med; 2010 Jun; 207(6):1153-60. PubMed ID: 20457758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active dissemination of cellular antigens by DCs facilitates CD8
    Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
    Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
    Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell subsets in lymph nodes are characterized by the specific draining area and influence the phenotype and fate of primed T cells.
    Bode U; Lörchner M; Ahrendt M; Blessenohl M; Kalies K; Claus A; Overbeck S; Rink L; Pabst R
    Immunology; 2008 Apr; 123(4):480-90. PubMed ID: 18028375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spreading the load: Antigen transfer between migratory and lymph node-resident dendritic cells promotes T-cell priming.
    Mueller SN
    Eur J Immunol; 2017 Oct; 47(10):1798-1801. PubMed ID: 28845904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice.
    Hamilton-Easton A; Eichelberger M
    J Virol; 1995 Oct; 69(10):6359-66. PubMed ID: 7666537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
    Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
    J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
    Noubade R; Majri-Morrison S; Tarbell KV
    Front Immunol; 2019; 10():1014. PubMed ID: 31143179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
    Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
    Front Immunol; 2018; 9():2775. PubMed ID: 30542351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.
    Arabpour M; Lebrero-Fernandez C; Schön K; Strömberg A; Börjesson V; Lahl K; Ballegeer M; Saelens X; Angeletti D; Agace W; Lycke N
    Mucosal Immunol; 2022 Apr; 15(4):745-761. PubMed ID: 35418673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With
    Li Y; Mateu E
    Front Immunol; 2021; 12():674185. PubMed ID: 34177915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytes as effector cells: activated Ly-6C(high) mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells.
    Leirião P; del Fresno C; Ardavín C
    Eur J Immunol; 2012 Aug; 42(8):2042-51. PubMed ID: 22585535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity.
    Liang Y; Hannan R; Fu YX
    Clin Cancer Res; 2021 Jul; 27(14):3818-3824. PubMed ID: 33692027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.